The relationship between the pan-immune-inflammation value and long-term prognoses in patients with hypertension: National Health and Nutrition Examination Study, 1999-2018.

ABSTRACT:

Background

Direct antihypertensive therapy in hypertensive patients with a high CVD risk can reduce the incidence of cardiovascular death but increase adverse cardiovascular events, so additional ways to identify hypertensive patients at high risk may be needed. Studies have shown that immunity and inflammation affect the prognoses of patients with hypertension and that the pan-immune-inflammation value (PIV) is an index to assess immunity and inflammation, but few studies have applied the PIV index to patients with hypertension.

Objective

To explore the relationship between the PIV and long-term all-cause and cardiovascular mortality in patients with hypertension.

Method

Data from the National Health and Nutrition Examination Survey (NHANES) 1999-2018 with a mortalit

SUBMITTER: Wu B 

PROVIDER: S-EPMC10017977 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature